Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Gallego

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Expert Opinion on Drug Safety|March 7, 2014
Dabigatran etexilate for venous thromboembolism: a safety evaluationRichard Brown, Gregory Yh Lip, Pilar Gallego
Cardiac Electrophysiology Clinics|April 12, 2016
Common Questions in Anticoagulation Management in Atrial FibrillationPilar Gallego, Vanessa Roldán, Gregory Y H Lip
American Journal of Respiratory and Critical Care Medicine|May 16, 2013
Conventional and new oral anticoagulants in the treatment of chest disease and its complicationsPilar Gallego, Vanessa Roldan, Gregory Y H Lip
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2013
Novel oral anticoagulants in cardiovascular diseasePilar Gallego, Vanessa Roldán, Gregory Y H Lip
Therapeutic Advances in Drug Safety|August 2, 2014
Safety of new oral anticoagulant drugs: a perspectiveJuan Antonio Vílchez, Pilar Gallego, Gregory Y H Lip
Thrombosis and Haemostasis|February 21, 2014
Circulating microparticles: challenges and perspectives of flow cytometric assessmentEduard Shantsila, Silvia Montoro-García, Pilar Gallego, et al.
Health and Quality of Life Outcomes|August 29, 2021
Anxiety, trauma and well-being in health-care professionals during COVID-19 first wave in Spain: the moderating role of personal protection equipment availabilityMiriam Bajo, Pilar Gallego, Maria Stavraki, et al.
European Journal of Public Health|March 12, 2014
Recent changes in school-based policies on physical activity and nutrition in SpainPilar Gallego, Iñaki Galán, María José Medrano, et al.
Frontiers in Medicine|July 16, 2026
Rechallenge of ruxolitinib after momelotinib-related toxicity in a 74-yo woman with secondary myelofibrosis: a case reportJose Miguel Torregrosa Diaz, Laura Cailly, Maria Pilar Gallego Hernanz, et al.
International Orthopaedics|May 23, 2009
Comparative study of the use of electromagnetic fields in patients with pseudoarthrosis of tibia treated by intramedullary nailingJuan L Cebrián, Pilar Gallego, Alberto Francés, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Expert Opinion on Drug Safety|March 7, 2014
Dabigatran etexilate for venous thromboembolism: a safety evaluationRichard Brown, Gregory Yh Lip, Pilar Gallego
Cardiac Electrophysiology Clinics|April 12, 2016
Common Questions in Anticoagulation Management in Atrial FibrillationPilar Gallego, Vanessa Roldán, Gregory Y H Lip
American Journal of Respiratory and Critical Care Medicine|May 16, 2013
Conventional and new oral anticoagulants in the treatment of chest disease and its complicationsPilar Gallego, Vanessa Roldan, Gregory Y H Lip
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2013
Novel oral anticoagulants in cardiovascular diseasePilar Gallego, Vanessa Roldán, Gregory Y H Lip
Therapeutic Advances in Drug Safety|August 2, 2014
Safety of new oral anticoagulant drugs: a perspectiveJuan Antonio Vílchez, Pilar Gallego, Gregory Y H Lip
Thrombosis and Haemostasis|February 21, 2014
Circulating microparticles: challenges and perspectives of flow cytometric assessmentEduard Shantsila, Silvia Montoro-García, Pilar Gallego, et al.
Health and Quality of Life Outcomes|August 29, 2021
Anxiety, trauma and well-being in health-care professionals during COVID-19 first wave in Spain: the moderating role of personal protection equipment availabilityMiriam Bajo, Pilar Gallego, Maria Stavraki, et al.
European Journal of Public Health|March 12, 2014
Recent changes in school-based policies on physical activity and nutrition in SpainPilar Gallego, Iñaki Galán, María José Medrano, et al.
Frontiers in Medicine|July 16, 2026
Rechallenge of ruxolitinib after momelotinib-related toxicity in a 74-yo woman with secondary myelofibrosis: a case reportJose Miguel Torregrosa Diaz, Laura Cailly, Maria Pilar Gallego Hernanz, et al.
International Orthopaedics|May 23, 2009
Comparative study of the use of electromagnetic fields in patients with pseudoarthrosis of tibia treated by intramedullary nailingJuan L Cebrián, Pilar Gallego, Alberto Francés, et al.
Pageof 7